Mangrove Partners Teva Pharmaceutical Industries LTD Transaction History
Mangrove Partners
- $769 Million
- Q3 2024
A detailed history of Mangrove Partners transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Mangrove Partners holds 2,147,141 shares of TEVA stock, worth $45 Million. This represents 5.03% of its overall portfolio holdings.
Number of Shares
2,147,141
Previous 2,762,154
22.27%
Holding current value
$45 Million
Previous $44.9 Million
13.8%
% of portfolio
5.03%
Previous 5.04%
Shares
2 transactions
Others Institutions Holding TEVA
# of Institutions
627Shares Held
573MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$900 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$759 Million35.87% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L334.5MShares$723 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$604 Million3.32% of portfolio
-
Exor Capital LLP London, X026.5MShares$555 Million14.79% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $23.3B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...